| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915944 | Nuclear Medicine and Biology | 2015 | 33 Pages |
Abstract
The early response to trastuzumab in mice bearing SKOV-3 xenografts was successfully monitored by SPECT imaging using 99mTc-peptide-ZHER2:342. This approach may be valuable in monitoring the therapeutic response in HER 2-positive tumours under HER2-targeted therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jingmian Zhang, Xinming Zhao, Shijie Wang, Na Wang, Jingya Han, Lizhuo Jia, Xiuchun Ren,